Multi-College Bystander Efficacy Evaluation
Public ClinicalTrials.gov record NCT02659423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Growing Researcher and College Communities Supporting Violence Prevention Research
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Bystander interventions, recognized as promising violence prevention strategies, are unique in their engagement of all community members to 1) recognize situations that may become violent and 2) learn to safely and effectively intervene to reduce violence risk. Based on their promise, the Campus Sexual Violence Elimination Act (SaVE) now requires all publicly-funded colleges to provide bystander intervention. With SaVE's policy intervention requiring bystander interventions, a "natural experiment" has arisen to determine the relative efficacy of students' bystander training across multiple colleges. Investigators propose a quasi-experimental design (using fractional factorials) to evaluate the relative efficacy of three bystander interventions to reduce violence in college communities. Green Dot will be one of three bystander interventions evaluated. A recent rigorous evaluation has found that Green Dot is associated with a 20-40% reduction in VAW in college and high school settings. In aim 1, investigators will compare the relative efficacy of bystander interventions to a) increase bystander efficacy and behaviors, b) reduce violence acceptance, c) reduce interpersonal violence victimization and perpetration, and d) increase program cost effectiveness. The three main bystander groups compared will be: exclusively online training, Green Dot (speeches and intensive bystander training), and other skills-based bystander training. Program efficacy data will be obtained from student surveys, campus crime statistics, and surveys with college staff and administrators responsible for selecting and implementing bystander interventions. In aim 2, investigators seek to grow communities of VAW prevention researchers. Researcher communities will form through researchers' engagement with college recruitment, survey design, data collection and analyses. Specifically investigators will determine the efficacy of this program to increase VAW prevention research productivity defined as a) increasing research skills and b) increasing research communications measured as manuscript submissions, presentations, and publications. This natural experiment will generate new understanding into efficacy of how bystander programs work. This natural experiment will also provide the VAW research community an opportunity to increase our skill-sets and share our experiences with and help grow the next generation of VAW prevention researchers.
Study identification
- NCT ID
- NCT02659423
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2015
- Primary completion
- May 31, 2019
- Completion
- Nov 30, 2020
- Last update posted
- Mar 14, 2021
2016 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Kentucky | Lexington | Kentucky | 40536-0293 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02659423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 14, 2021 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02659423 live on ClinicalTrials.gov.